Abstract
Cytotoxic chemotherapy is used increasingly in the management of bladder cancer. The agents used, intravesically and systemically, are reviewed, together with preliminary reports of certain trials of adjuvant chemotherapy that have now been activated.
Publication types
-
Clinical Trial
-
Comparative Study
-
Review
MeSH terms
-
Administration, Topical
-
Antineoplastic Agents / administration & dosage*
-
Clinical Trials as Topic
-
Doxorubicin / administration & dosage
-
Drug Evaluation
-
Drug Therapy, Combination
-
Ethoglucid / administration & dosage
-
Europe
-
Humans
-
Neoplasm Invasiveness
-
Prognosis
-
Random Allocation
-
Thiotepa / administration & dosage
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / radiotherapy
-
Urinary Bladder Neoplasms / surgery
Substances
-
Antineoplastic Agents
-
Ethoglucid
-
Doxorubicin
-
Thiotepa